BeOne Medicines Ltd. (ONC) › Operating IncomeBeOne Medicines Ltd. (ONC) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2014: -$15.76M2015: -$56.74M2016: -$117.06M2017: -$98.46M2018: -$705.77M2019: -$959.89M2020: -$1.66B2021: -$1.44B2022: -$1.79B2023: -$1.21B2024: -$568.20M2025: $447.14M$447.14M2014Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025$447.14M+178.7%2024-$568.20M+53.0%2023-$1.21B+32.5%2022-$1.79B-24.4%2021-$1.44B+13.2%2020-$1.66B-72.7%2019-$959.89M-36.0%2018-$705.77M-616.8%2017-$98.46M+15.9%2016-$117.06M-106.3%2015-$56.74M-260.1%2014-$15.76M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share